Literature DB >> 16805834

Molecular determinants of ginkgolide binding in the glycine receptor pore.

Rebecca Hawthorne1, Brett A Cromer, Hooi-Ling Ng, Michael W Parker, Joseph W Lynch.   

Abstract

Ginkgolides are potent blockers of the glycine receptor Cl- channel (GlyR) pore. We sought to identify their binding sites by comparing the effects of ginkgolides A, B and C and bilobalide on alpha1, alpha2, alpha1beta and alpha2beta GlyRs. Bilobalide sensitivity was drastically reduced by incorporation of the beta subunit. In contrast, the sensitivities to ginkgolides B and C were enhanced by beta subunit expression. However, ginkgolide A sensitivity was increased in the alpha2beta GlyR relative to the alpha2 GlyR but not in the alpha1beta GlyR relative to the alpha1 GlyR. We hypothesised that the subunit-specific differences were mediated by residue differences at the second transmembrane domain 2' and 6' pore-lining positions. The increased ginkgolide A sensitivity of the alpha2beta GlyR was transferred to the alpha1beta GlyR by the G2'A (alpha1 to alpha2 subunit) substitution. In addition, the alpha1 subunit T6'F mutation abolished inhibition by all ginkgolides. As the ginkgolides share closely related structures, their molecular interactions with pore-lining residues were amenable to mutant cycle analysis. This identified an interaction between the variable R2 position of the ginkgolides and the 2' residues of both alpha1 and beta subunits. These findings provide strong evidence for ginkgolides binding at the 2' pore-lining position.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16805834     DOI: 10.1111/j.1471-4159.2006.03875.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Cys-loop receptor channel blockers also block GLIC.

Authors:  Mona Alqazzaz; Andrew J Thompson; Kerry L Price; Hans-Georg Breitinger; Sarah C R Lummis
Journal:  Biophys J       Date:  2011-12-20       Impact factor: 4.033

Review 2.  What single-channel analysis tells us of the activation mechanism of ligand-gated channels: the case of the glycine receptor.

Authors:  Lucia G Sivilotti
Journal:  J Physiol       Date:  2009-09-21       Impact factor: 5.182

3.  Mechanism of action of the insecticides, lindane and fipronil, on glycine receptor chloride channels.

Authors:  Robiul Islam; Joseph W Lynch
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

4.  Binding sites for bilobalide, diltiazem, ginkgolide, and picrotoxinin at the 5-HT3 receptor.

Authors:  A J Thompson; R K Duke; S C R Lummis
Journal:  Mol Pharmacol       Date:  2011-04-19       Impact factor: 4.436

5.  An improved ivermectin-activated chloride channel receptor for inhibiting electrical activity in defined neuronal populations.

Authors:  Timothy Lynagh; Joseph W Lynch
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

Review 6.  Advantages of an antagonist: bicuculline and other GABA antagonists.

Authors:  Graham A R Johnston
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

7.  Ginkgolide X is a potent antagonist of anionic Cys-loop receptors with a unique selectivity profile at glycine receptors.

Authors:  Anders A Jensen; Marianne L Bergmann; Tommy Sander; Thomas Balle
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

8.  Mixed antagonistic effects of the ginkgolides at recombinant human ρ1 GABAC receptors.

Authors:  Shelley H Huang; Trevor M Lewis; Sarah C R Lummis; Andrew J Thompson; Mary Chebib; Graham A R Johnston; Rujee K Duke
Journal:  Neuropharmacology       Date:  2012-07-22       Impact factor: 5.250

9.  Ginkgolide B and bilobalide block the pore of the 5-HT₃receptor at a location that overlaps the picrotoxin binding site.

Authors:  Andrew J Thompson; Gavin E Jarvis; Rujee K Duke; Graham A R Johnston; Sarah C R Lummis
Journal:  Neuropharmacology       Date:  2010-11-05       Impact factor: 5.250

Review 10.  Discriminating between 5-HT₃A and 5-HT₃AB receptors.

Authors:  A J Thompson; S C R Lummis
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.